Abstract
The term “adjuvant” originates from the Latin word adjuvare, which means to help or aid. An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens (1). In a broad sense, immunologic adjuvants include certain cytokines and other immunomodulatory molecules (i.e. chemokines and costimulatory factors) or their expression vectors. Since these adjuvants are described elsewhere in this book, here, we are concerned only with adjuvants that are derived from microorganisms and plants or are synthesized chemically.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Vogel, F. R. (1995) Immunologic adjuvants for modern vaccine formulations, in Combined Vaccine and Simultaneous Administration—Current Issues and Perspectives, Ann. NY Acad. Sci., vol. 754 (Williams, J. C., Goldenthal, K. L., Burns, D. L., and Lewis, B. P. J., eds.) N Y Academy of Sciences, New York. pp. 153–160.
Powell, M. F. and Newman, M. J., eds. (1995) Vaccine Design: The Subunit and Adjuvant Approach, Plenum Press, New York.
Golding, B. and Scott, D. E. (1995) Vaccine Strategies: Targetting helper T cell responses, in Combined Vaccine and Simultaneous Administration—Current Issues and Perspectives, Ann. NY Acad. Sci. vol. 754 (Williams, J. C., Goldenthal, K. L., Burns, D. L., and Lewis, B. P. J., eds.) NY Academy of Sciences, New York. pp. 126–137.
Gupta, R. K. and Siber, G. R. (1995) Adjuvants for human vaccines-current status, problems and future prospects. Vaccine 13, 1263–1276.
Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996) Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J. Exp. Med. 184, 1555–1560.
Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578–8583.
Tsuji, T., Fukushima, J., Hamajima, K., Ishii, N., Aoki, I., Xin, K.-Q., et al. (1997) HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology 90, 1–6.
Sasaki, S., Tsuji, T., Hamajima, K., Fukushima, J., Ishii, N., Kaneko, T., et al. (1997) Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against Human Immunodeficiency Virus Type 1. Infect. Immun. 65, 3520–3528.
Sasaki, S., Sumino, K., Hamajima, K., Fukushima, J., Ishii, N., Kawamoto, S., et al. (1998) Induction of systemic and mucosal immune responsees to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72, 4931–4939.
Kuklin, N., Daheshia, M., Karem, K., Manickan, E., and Rouse, B. T. (1997) Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71, 3138–3145.
Watanabe, A., Raz, E., Kohsaka, H., Tighe, H., Baird, S. M., Kipps, T. J., and Carson, D. A. (1993) Induction of antibodies to a kappa V region by gene immunization. J. Immunol. 151, 2871–2876.
Xiang, Z. Q., and Ertl, H. C. J. (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129–135.
Tsuji, T., Hamajima, K., Fukushima, J., Xin, K.-Q., Ishii, N., Aoki, I. (1997) Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158, 4008–4014.
Iwasaki, A., Stiernholm, B. J. N., Chan, A. K., Berinstein, N. L., and Barber, B. H. (1997) Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591–4601.
Gregoriadis, G., Saffie, R., and de Souza, J. B. (1997) Liposome-mediated DNA vaccination. FEBS Lett. 402, 107–110.
Ishii, N., Fukushima, J., Kaneko, T., Okada, E., Tani, K., Tanaka, S.-I., et al. (1997) Cationic liposomes are a strong adjuvant of DNA vaccine for a Human Immunodeficiency Virus Type-1 (HIV-1). AIDS Res. Hum. Retroviruses 13, 1421–1428.
Gao, X. and Huang, L. (1991) A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Comm. 179, 280–285.
Toda, S., Ishii, N., Okada, E., Kusakabe, K.-I., Arai, H., Hamajima, K., et al. (1997) HIV-1 specific cell-mediated immune responses induced by DNA vaccination are enhanced by mannan-coated liposomes and inhibited by anti-inter-feron (IFN)-gamma antibody. Immunology 92, 111–117.
Sasaki, S., Fukushima, J., Arai, H., Kusakabe, K., Hamajima, K., Ishii, N., et al. (1997) Human immunodeficiency virus type 1 specific immune response induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27, 3121–3129.
Sugimoto, M., Ohishi, K., Fukasawa, M., Shikata, K., Kawai, H., Itakura, H., et al. (1995) Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity. FEBS Lett. 363, 53–56.
Wang, S., Manning, S., Kensil, C. R., and Lu, S. (1997) QS-21 is effective in boosting anti-HIV-1 Env antibody responses induced by DNA immunization. 9th Annual Meeting of The National Cooperative Vaccine Development Groups for AIDS, poster abstract 15. Bethesda, MD, USA.
Sasaki, S., Hamajima, K., Fukushima, J., Tsuji, T., Xin, K.-Q., Ishii, N., et al. (1997) Adjuvant effect of ubenimex on a DNA vaccine for human immunodeficiency virus type-1. Clin. Exp. Immunol. 111, 30–35.
Hamajima, K., Sasaki, S., Fukushima, J., Kaneko, T., Xin, K.-Q., Kudo, I., and Okuda, K. (1998) Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethyl cellulose augment mucosal antibody production and cell-mediated immune response. Clin. Immunol. Immunopathol. 80, 205–210.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Sasaki, S., Okuda, K. (2000). The Use of Conventional Immunologic Adjuvants in DNA Vaccine Preparations. In: Lowrie, D.B., Whalen, R.G. (eds) DNA Vaccines. Methods in Molecular Medicine™, vol 29. Humana Press. https://doi.org/10.1385/1-59259-688-6:241
Download citation
DOI: https://doi.org/10.1385/1-59259-688-6:241
Publisher Name: Humana Press
Print ISBN: 978-0-89603-580-5
Online ISBN: 978-1-59259-688-1
eBook Packages: Springer Protocols